Clinical Trial Update: Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer [Phase 1]

View source ↗

Summary

Phase I trial of MT110 in multiple solid tumors has completed enrollment, evaluating MT110 in lung cancer (non-small cell and small cell), gastric cancer, gastr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Prostate Cancer
• Small Cell Lung Cancer

Drugs mentioned

• MT110 (MT110)

Snippet

Sponsor: Amgen Research (Munich) GmbH | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED